Literature DB >> 21567923

Lethal presentation of neurofibromatosis and Noonan syndrome.

Carlos E Prada1, Yuri A Zarate, Sean Hagenbuch, Anne Lovell, Elizabeth K Schorry, Robert J Hopkin.   

Abstract

Neurofibromatosis type 1 and Noonan syndrome are both common genetic disorders with autosomal dominant inheritance. Similarities between neurofibromatosis type 1 and Noonan syndrome have been noted for over 20 years and patients who share symptoms of both conditions are often given the diagnosis of neurofibromatosis-Noonan syndrome (NFNS). The molecular basis of these combined phenotypes was poorly understood and controversially discussed over several decades until the discovery that the syndromes are related through disturbances of the Ras pathway. We present an infant male with coarse facial features, severe supravalvar pulmonic stenosis, automated atrial tachycardia, hypertrophic cardiomyopathy, airway compression, severe neurological involvement, and multiple complications that lead to death during early infancy. The severity of clinical presentation and significant dysmorphic features suggested the possibility of a double genetic disorder in the Ras pathway instead of NFNS. Molecular analysis showed a missense mutation in exon 25 of the NF1 gene (4288A>G, p.N1430D) and a pathogenic mutation on exon 8 (922A>G, p.N308D) of the PTPN11 gene. Cardiovascular disease has been well described in patients with Noonan syndrome with PTPN11 mutations but the role of haploinsufficiency for neurofibromin in the heart development and function is not yet well understood. Our case suggests that a double genetic defect resulting in the hypersignaling of the Ras pathway may lead to complex cardiovascular abnormalities, cardiomyopathy, refractory arrhythmia, severe neurological phenotype, and early death.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21567923     DOI: 10.1002/ajmg.a.33996

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  9 in total

Review 1.  RASopathy Gene Mutations in Melanoma.

Authors:  Ruth Halaban; Michael Krauthammer
Journal:  J Invest Dermatol       Date:  2016-05-25       Impact factor: 8.551

2.  A rasopathy phenotype with severe congenital hypertrophic obstructive cardiomyopathy associated with a PTPN11 mutation and a novel variant in SOS1.

Authors:  Jill A Fahrner; Aisha Frazier; Suha Bachir; Michael F Walsh; Carolyn D Applegate; Reid Thompson; Marc K Halushka; Anne M Murphy; Meral Gunay-Aygun
Journal:  Am J Med Genet A       Date:  2012-05-14       Impact factor: 2.802

3.  p.Arg1809Cys substitution in neurofibromin is associated with a distinctive NF1 phenotype without neurofibromas.

Authors:  Valentina Pinna; Valentina Lanari; Paola Daniele; Federica Consoli; Emanuele Agolini; Katia Margiotti; Irene Bottillo; Isabella Torrente; Alessandro Bruselles; Caterina Fusilli; Anna Ficcadenti; Sara Bargiacchi; Eva Trevisson; Monica Forzan; Sandra Giustini; Chiara Leoni; Giuseppe Zampino; Maria Cristina Digilio; Bruno Dallapiccola; Maurizio Clementi; Marco Tartaglia; Alessandro De Luca
Journal:  Eur J Hum Genet       Date:  2014-11-05       Impact factor: 4.246

4.  The Complexity of Pediatric Multifocal Atrial Tachycardia and Its Prognostic Factors.

Authors:  Seung Min Baek; Hyun Chung; Mi Kyoung Song; Eun Jung Bae; Gi Beom Kim; Chung Il Noh
Journal:  Korean Circ J       Date:  2018-02       Impact factor: 3.243

5.  Prevalence, Type, and Molecular Spectrum of NF1 Mutations in Patients with Neurofibromatosis Type 1 and Congenital Heart Disease.

Authors:  Valentina Pinna; Paola Daniele; Giulio Calcagni; Lucio Mariniello; Roberta Criscione; Chiara Giardina; Francesca Romana Lepri; Hossein Hozhabri; Angela Alberico; Stefania Cavone; Annunziata Tina Morella; Roberta Mandile; Francesca Annunziata; Niccolò Di Giosaffatte; Maria Cecilia D'Asdia; Paolo Versacci; Rossella Capolino; Pietro Strisciuglio; Sandra Giustini; Daniela Melis; Maria Cristina Digilio; Marco Tartaglia; Bruno Marino; Alessandro De Luca
Journal:  Genes (Basel)       Date:  2019-09-04       Impact factor: 4.096

6.  One NF1 Mutation may Conceal Another.

Authors:  Laurence Pacot; Cyril Burin des Roziers; Ingrid Laurendeau; Audrey Briand-Suleau; Audrey Coustier; Théodora Mayard; Camille Tlemsani; Laurence Faivre; Quentin Thomas; Diana Rodriguez; Sophie Blesson; Hélène Dollfus; Yvon-Gauthier Muller; Béatrice Parfait; Michel Vidaud; Brigitte Gilbert-Dussardier; Catherine Yardin; Benjamin Dauriat; Christian Derancourt; Dominique Vidaud; Eric Pasmant
Journal:  Genes (Basel)       Date:  2019-08-22       Impact factor: 4.096

7.  Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations?

Authors:  Adila Alkindy; Nadia Chuzhanova; Usha Kini; David N Cooper; Meena Upadhyaya
Journal:  Hum Genomics       Date:  2012-08-13       Impact factor: 4.639

8.  Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas.

Authors:  Michael Krauthammer; Yong Kong; Antonella Bacchiocchi; Perry Evans; Natapol Pornputtapong; Cen Wu; Jamie P. McCusker; Shuangge Ma; Elaine Cheng; Robert Straub; Merdan Serin; Marcus Bosenberg; Stephan Ariyan; Deepak Narayan; Mario Sznol; Harriet M Kluger; Shrikant Mane; Joseph Schlessinger; Richard P Lifton; Ruth Halaban
Journal:  Nat Genet       Date:  2015-07-27       Impact factor: 41.307

9.  Co-occurrence of neurofibromatosis type 1 and optic nerve gliomas with autosomal dominant polycystic kidney disease type 2.

Authors:  Ramón Peces; Rocío Mena; Yolanda Martín; Concepción Hernández; Carlos Peces; Dolores Tellería; Emilio Cuesta; Rafael Selgas; Pablo Lapunzina; Julián Nevado
Journal:  Mol Genet Genomic Med       Date:  2020-06-13       Impact factor: 2.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.